Product Information

ZAFIRLUKAST 20 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.6314 per EA under NDC 64380018801. Its NADAC has been published 221 times since Aug 31, 2022.

FDA first approved this application on Sep 26, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZAFIRLUKAST 20 MG TABLET

zafirlukast
$0.6314per EA

Strength

20 mg/1

NDC

64380018801

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ZAFIRLUKAST

Approval Type

New Drug (NDA)

FDA Application

NDA020547

FDA Approved

9/26/1996

TE Code

AB

On Market Since

8/1/2022

Pharmacological Classes

Cytochrome P450 2C9 Inhibitors
Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price Statistics

The NADAC for ZAFIRLUKAST 20 MG TABLET has been published 221 times since Aug 31, 2022, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6314 per EA
All-time high$0.9991 (Dec 13, 2023)
All-time low$0.4512 (Nov 20, 2024)
52-week high$0.6791
52-week low$0.6234
Median price$0.6798
Average price$0.7277
Largest weekly change-33.6% (Nov 20, 2024)
Weeks tracked221
Tracking sinceAug 31, 2022

Price History

1W

+1.1%

1M

+1.3%

3M

-1.9%

6M

-5.2%

1Y

-7.8%

3Y

-20.7%

5Y

N/A

All

-24.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the zafirlukast market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ZAFIRLUKAST 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZAFIRLUKAST 20 MG TABLET, manufactured by Strides Pharma Inc., is $0.6314 per EA (NDC 64380018801), effective Nov 18, 2026.

How has the price of ZAFIRLUKAST 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZAFIRLUKAST 20 MG TABLET has declined 24.9%. It has been tracked across 221 weekly CMS publications since Aug 31, 2022.

What are the highest and lowest recorded NADAC prices for ZAFIRLUKAST 20 MG TABLET?

Since Aug 31, 2022, the NADAC for ZAFIRLUKAST 20 MG TABLET has ranged from a low of $0.4512 (Nov 20, 2024) to a high of $0.9991 (Dec 13, 2023), with a median of $0.6798 per EA.

Are there cheaper alternatives to ZAFIRLUKAST 20 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ZAFIRLUKAST 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ZAFIRLUKAST 20 MG TABLET?

ZAFIRLUKAST 20 MG TABLET (NDC 64380018801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.